TNFSF10 and neoplasm: Conceptually, active targeting through fusion with an antibody moiety should i) result in increased accumulation of the fusion proteins at the target site, i.e. increase the local concentration in the tumor, and ii) result in a membrane-like presentation of TRAIL, i.e. generating a multivalent TRAIL surface leading to receptor clustering and efficient activation of cell death signals [8, 39].